Hydrocephalus is a fluid build-up in the brain, which puts pressure on the brain. It is common in older adults and infants. Headache, impaired vision, cognitive difficulties, coordination ability loss, and incontinence are among the symptoms experienced by patients with hydrocephalus. It may cause head enlargement in infants. A hydrocephalus shunt is the surgical insertion of a drainage system that helps drain out excess fluid from the brain.
The hydrocephalus shunts market is segmented on the basis of age group, type, product, end user, and geography. By geography, the market is broadly segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. This report offers insights and in-depth analysis of the market with an emphasis on parameters such as market trends and market dynamics. It also highlights the competitive analysis of the globally leading players in the hydrocephalus shunts market.
Hydrocephalus is more prevalent in children and infants than adult population worldwide. Additionally, the disease is also prevalent in people aged 60 and above. According to the Hydrocephalus Association, the disease affects over 1 million Americans. Additionally, the incidence rate of hydrocephalus in the US is 1 in every 770 babies.
According to the article "Global hydrocephalus epidemiology and incidence: systematic review and meta-analysis," published in the Journal of Neurosurgery (JNS) in 2019, low-income and middle-income countries, particularly those in Africa and Latin America, incur the most significant burden of hydrocephalus. The article also states that Sub-Saharan Africa witnessed an annual incidence of more than 225,000 new cases of infant hydrocephalus, i.e., 750 new cases per 100,000 live births. Moreover, in a European cohort, the incidence rate was estimated at 110 cases of infantile hydrocephalus per 100,000 live births.
The treatment approach of hydrocephalus highly focuses on managing CSF through medical devices named shunts. The shunt systems remove excess cerebrospinal fluid from the brain and divert it to other body parts, wherein it is absorbed as a part of the circulatory process. Thus, the high incidence of hydrocephalus leads drives the demand for hydrocephalus shunts, thereby boosting the hydrocephalus market growth
Based on the product, the hydrocephalus shunts market is segmented into hydrocephalus valves, hydrocephalus catheters, neuronavigation systems, and others. The hydrocephalus valves segment held the largest market share in 2021, and it is also anticipated to register the highest CAGR of 3.6% during the forecast period. The market for hydrocephalus valves is further bifurcated into adjustable pressure valves and fix pressure valves.
Based on type, the hydrocephalus shunts market is segmented into ventriculo-peritoneal, ventriculoatrial, ventriculo-pleural, and lumbo-peritoneal. In 2021, the ventriculo-peritoneal segment held the largest share of the market. Moreover, the market for this segment is expected to grow at a significant CAGR of 3.7% during the forecast period.
Based on age group, the hydrocephalus shunts market is segmented into pediatric and adults. In 2021, the pediatric segment held a larger share of the market. It is further estimated to register a significant CAGR of 3.5% during the forecast period.
The regional trends and factors influencing the Hydrocephalus Shunts Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Hydrocephalus Shunts Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 286.19 Million |
| Market Size by 2028 | US$ 360.01 Million |
| Global CAGR (2021 - 2028) | 3.4% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Age Group
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
The Hydrocephalus Shunts Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Hydrocephalus Shunts Market are:
Disclaimer: The companies listed above are not ranked in any particular order.
Based on end user, the hydrocephalus shunts market is segmented into hospitals, ambulatory surgical centers, and others. The hospital segment held the largest market share in 2021, and it is expected to register the highest CAGR of 3.8% during the forecast period.
Organic strategies such as product launches and approvals are highly adopted growth strategies by companies in the hydrocephalus shunts market. A few of the recent key market developments are listed below.
Global hydrocephalus shunts market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. The North America region held the largest market for the hydrocephalus shunts market during the forecast period. The large share of North America in the global hydrocephalus shunts market is attributed to factors such as the growing usage of innovative technologies that offer faster discovery and product development. Moreover, wide-ranging R&D activities by numerous organizations support new product launches in the region ultimately driving the overall hydrocephalus shunts market during the forecast period.
Thermo Fisher Scientific and Agilent Technologies, Inc. are the top two companies that hold huge market shares in the Hydrocephalus Shunts market.
The hydrocephalus shunts market majorly consists of the players such as B. Braun Melsungen AG (CHRISTOPH MIETHKE GMBH & CO. KG); Sophysa; HpBio Próteses, inc.; Integra LifeSciences Holdings Corporation; KANEKA MEDIX CORP.; Medtronic; Natus Medical Incorporated; Spiegelberg GmbH & Co. KG, and Desu Medical. among others.
The hospitals segment dominated the global hydrocephalus shunts market and held the largest market share of 54.99% in 2021.
The pediatric segment dominated the global hydrocephalus shunts market and held the largest market share of 57.17% in 2021.
The ventriculo-peritoneal segment dominated the global hydrocephalus shunts market and accounted for the largest market share of 44.44% in 2021.
The hydrocephalus valves segment held the largest share of the market in the global hydrocephalus shunts market and held the largest market share of 61.85% in 2021.
Shunt, the surgical insertion of a drainage system is the most common remedy for hydrocephalus. It drains extra cerebrospinal fluid from the brain to another part of the body such as the abdomen, where it can be more easily absorbed. It consists of a long and flexible tube with a valve that keeps fluid from the brain flowing in the right approach and at the proper rate.
Key factors that are driving the growth of this market are the increasing prevalence of hydrocephalus and increasing advancement in hydrocephalus valves.
The CAGR value of the Hydrocephalus Shunts market during the forecasted period of 2022-2028 is 3.4%.